Valeritas Holdings Inc. (fka VLRXQ)

[02opida]

VLRX

[BidnessMan]

Keto carnivore - even better.

[John_Langston]

[cottonmather]

?????

[BidnessMan]

Keto.

[uther3055]

I’m not seeing what is keeping this down

[Maurice King Solomon]

Metoo

[doc7]

going forward looks good I may increase my holdings at this level

[hottip1]

Market does not like financials. They look like an improvement to me

[doc7]

why the drop pre market annual looked good ?

[manisero66]

Iam of the opinion that Roche has to keep its law dpto. busy. They lost all demands.

[Tomog]

Does anyone have an opinion of Roche patent lawsuit against VLRX? Bloomberg Law mentioned on 2/25/2019. Lawsuit filed on 2/22/2019 by Roche. I am concerned because they have much deeper pockets.

[Maurice King Solomon]

Sweet

[cottonmather]

Few things travel a straight line unless you are in the back seat of a police car. Of course, incorporate a stop. Don't fall in love. No one is a friend. Wear a cup. Good luck.

[Maurice King Solomon]

I like your analysis

[cottonmather]

Yesterday was a flagpole - spike with high volume. A brief consolidation is likely. Technical players are beginning to stack positions. Patience.

[BottomBounce]

$VLRX .55 by end of day imo

[cottonmather]

I am Type II controlling A1C with Invokana. I am also a professional technical trader who ignores fundamentals because people lie. This is a technical play only for me.

[BottomBounce]

$VLRX Zacks Investment Research, Inc. upgrades VALERITAS HOLDINGS INC from HOLD to BUY.

[BottomBounce]

$VLRX 371 million people in the world have Diabetes
Diabetes is now a disease that affects 371 million people worldwide, and 187 million of them do not even know they have the disease, according to the International Diabetes Federation (IDF).

[cottonmather]

VLRX pumping up https://stockcharts.com/public/1164099

[ClayTrader]

* * $VLRX Video Chart 02-21-2019 * *

Link to Video - click here to watch the technical chart video

[BottomBounce]

$VLRX Valeritas to Present at Upcoming Investor Conferences
Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced the Company plans to participate in two upcoming investor conferences:

-- February 28, 2019, Valeritas' management is scheduled to participate in the BTIG Snowbird Healthcare Conference in Snowbird, UT. Due to the format of this event, no webcast is available.

-- March 13, 2019 at 11:20 AM EST, Valeritas' management is scheduled to present at the Cowen & Co. 39th Annual Health Care Conference in Boston, MA. Interested parties can access the live and archived webcast at www.valeritas.com, under the investor relations section.

[BottomBounce]

$VLRX Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced positive clinical outcomes for V-Go compared to insulin pen devices for treating people with type 2 diabetes prescribed basal-bolus insulin therapy. The results were presented at the 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019) in Berlin, Germany.

This retrospective study was performed using electronic medical records of 148 patients from nine diabetes centers in the United States. Patients with uncontrolled blood sugar levels (A1c ≥ 7.0%) who were prescribed basal-bolus insulin therapy administered by insulin pen devices prior to using V-Go were included in the evaluation. At the third and seventh month of V-Go use, patients experienced statistically significant reductions in both A1c levels and total daily doses of insulin. A1c levels decreased by 1.04 and 1.11, respectively from a baseline A1c of 9.1%. The average total daily dose of insulin decreased by 25 and 24 units per day, respectively from a baseline dose of 82 units per day. Similar A1c reductions were experienced in patients prescribed > 50 units per day of basal or prandial insulin at baseline.

“We are excited to share these positive data from our clinical study at ATTD 2019,” said John Timberlake, President and Chief Executive Officer of Valeritas. “We believe the results of this study further support when basal-bolus insulin therapy is needed, the use of V-Go Wearable Insulin Delivery device can offer significant clinical benefit.”

About Valeritas Holdings, Inc.

Valeritas is a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. Valeritas’ flagship product, V-Go® Wearable Insulin Delivery device, is a simple, affordable, all-in-one basal-bolus insulin delivery option for patients with type 2 diabetes that is worn like a patch and can eliminate the need for taking multiple daily shots. V-Go administers a continuous preset basal rate of insulin over 24 hours, and it provides discreet on-demand bolus dosing at mealtimes. It is the only basal-bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type 2 diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R&D functions in Marlborough, Massachusetts.

More information is available at www.valeritas.com and our Twitter feed @Valeritas_US, www.twitter.com/Valeritas_US.

http://www.globenewswire.com/news-release/2019/02/21/1739155/0/en/Switching-to-Valeritas-V-Go-Wearable-Insulin-Delivery-Device-from-Insulin-Pen-Devices-for-Basal-Bolus-Therapy-Improved-Glycemic-Control-with-Less-Insulin.html?culture=en-us

[BottomBounce]

$VLRX $1+ coming

[doc7]

thanks wed'll see what happens I am in

[John_Langston]

I like the way you think.

[doc7]

real good news that is a product that could be a real blockbuster. As a pharmacist I know what a pain
the injections can be --both ways. r

[stockyupydowny]

BIG THINGS COMING HERE - nice loading buy insiders and retail lately

[Sumfest]

Valeritas Announces V-Go® is Preferred on Humana Part D Formularies

BRIDGEWATER, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch for patients with diabetes, today announced that Humana, one of the nation’s leading health and well-being companies in the United States, has given V-Go Preferred status on Humana’s Part D formularies.

“We are very excited that V-Go is now Preferred on Humana’s Medicare formularies, which will improve patient access to V-Go at an affordable monthly copay for its members with type 2 diabetes,” said Valeritas CEO, John Timberlake.

V-Go is available as Preferred on Humana’s Part D formularies, which include their MAPD and Enhanced PDP formularies.

[livingfree]

No worries on this one. Look for runup near February when financials are released. IMO 1.00 to 2.00 per share by March

[Maurice King Solomon]

Also many block trades

[uther3055]

With the insider buys you would think this would turn any day

[Maurice King Solomon]

When will this thing turn?

[Maurice King Solomon]

When will this thing turn?

[willlbone]

Bid under 30 cents

[420man]

Very possible!

[LiveLife]

Friday's activity seemed promising.

Maybe we rebound from here? https://stocktradingmodel.wordpress.com/

[Country Squire]

Backstabbed. Great post and find, When Management buys their own shares that's a Green Flag. Maybe not right away but in the future. GL

[420man]

Next?

[Backstabbed]

$VLRX - Look at all those form 4's filed about an hour ago!!

https://ih.advfn.com/stock-market/NASDAQ/valeritas-holdings-inc-VLRX/news

[ClayTrader]

* * $VLRX Video Chart 11-15-18 * *

Link to Video - click here to watch the technical chart video

[manisero66]

It seems the you aren´t going to sell many devices in Australia. All down as usual.

[ClayTrader]

* * $VLRX Video Chart 07-06-18 * *

Link to Video - click here to watch the technical chart video

[ClayTrader]

* * $VLRX Video Chart 06-25-18 * *

Link to Video - click here to watch the technical chart video

[General Grievous]

Interesting movement today

[mohsin123]

I noticed that some news releases done 2 or 3hours before the market opened how can I know or receive the news once it was released

I will be happy and thankful if some one explain or show me how

[TheFinalCD]

gap & trap so far


I think heres why https://investorshub.advfn.com/boards/read_msg.aspx?message_id=141767078

[crudeoil24]

SENS > https://investorshub.advfn.com/boards/read_msg.aspx?message_id=141712984

[crudeoil24]

Agree! conference in Baltimore. > SENS should pop from this conference as well. They had big news last Friday.